| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of a Notch 3 gene polymorphism with migraine susceptibility
|
Menon, S
|
|
2011
|
31 |
3 |
p. 264-270
|
artikel
|
| 2 |
A trans-cultural comparison of the organisation of care at headache centres world-wide
|
Bhola, Ria
|
|
2011
|
31 |
3 |
p. 316-330
|
artikel
|
| 3 |
Aura attacks from acute convexity subarachnoid haemorrhage not due to cerebral amyloid angiopathy
|
Field, DK
|
|
2011
|
31 |
3 |
p. 368-371
|
artikel
|
| 4 |
Cardiovascular risk factors associated with migraine among the elderly with a low income: The São Paulo Ageing & Health Study (SPAH)
|
Benseñor, Isabela M
|
|
2011
|
31 |
3 |
p. 331-337
|
artikel
|
| 5 |
Ciliary ganglioplegic migraine: Migraine-related prolonged mydriasis
|
Barriga, FJ
|
|
2011
|
31 |
3 |
p. 291-295
|
artikel
|
| 6 |
Comments on ‘Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers’
|
Vanmolkot, Floris
|
|
2011
|
31 |
3 |
p. 380-380
|
artikel
|
| 7 |
Differential activation of the middle-temporal complex to visual stimulation in migraineurs
|
Antal, Andrea
|
|
2011
|
31 |
3 |
p. 338-345
|
artikel
|
| 8 |
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
|
Blumenfeld, AM
|
|
2011
|
31 |
3 |
p. 301-315
|
artikel
|
| 9 |
Mendelian and complex causes of migraine: Bridging the gap
|
Joutel, Anne
|
|
2011
|
31 |
3 |
p. 259-261
|
artikel
|
| 10 |
Neurocognitive recovery in SMART syndrome: A case report
|
Bradshaw, Jennifer
|
|
2011
|
31 |
3 |
p. 372-376
|
artikel
|
| 11 |
Occipital nerve stimulation for chronic migraine—interpreting the ONSTIM feasibility trial
|
Schwedt, Todd J
|
|
2011
|
31 |
3 |
p. 262-263
|
artikel
|
| 12 |
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
|
Saper, Joel R
|
|
2011
|
31 |
3 |
p. 271-285
|
artikel
|
| 13 |
OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .
|
Torgovnick, Josh
|
|
2011
|
31 |
3 |
p. 377-377
|
artikel
|
| 14 |
Response to “OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .”
|
Aurora, Sheena
|
|
2011
|
31 |
3 |
p. 378-379
|
artikel
|
| 15 |
Serial polysomnography in hypnic headache
|
Holle, Dagny
|
|
2011
|
31 |
3 |
p. 286-290
|
artikel
|
| 16 |
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: Application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan*
|
Dodick, David W
|
|
2011
|
31 |
3 |
p. 296-300
|
artikel
|
| 17 |
Thanks to Reviewers
|
|
|
2011
|
31 |
3 |
p. 381-383
|
artikel
|
| 18 |
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
|
Yang, Min
|
|
2011
|
31 |
3 |
p. 357-367
|
artikel
|
| 19 |
Visual metacontrast masking in migraine
|
Shepherd, Alex J
|
|
2011
|
31 |
3 |
p. 346-356
|
artikel
|
Tijdschrift beschrijving